News & Updates

Show Multimedia Only

Esketamine demonstrates safety in real world

27 Oct 2025

The real-world use of esketamine nasal spray is safe and has a safety profile consistent with that established in clinical studies and current product labeling, reports a US study. No new safety signals have been noted.

Esketamine demonstrates safety in real world

27 Oct 2025

PHQ, HADS deemed acceptable for poststroke depression screening in Singapore

23 Oct 2025 by

Both the Patient Healthcare Questionnaire (PHQ) and the Hospital Anxiety and Depression Scale (HADS) are useful for identifying stroke survivors with depression in Singaporean inpatient rehabilitation care settings, as shown in a study.

PHQ, HADS deemed acceptable for poststroke depression screening in Singapore

23 Oct 2025

Slow-tempo music intervention does nothing to improve delirium outcomes in ventilated patients

23 Oct 2025

A slow-tempo music intervention falls short of reducing the duration and severity of delirium in older patients on mechanical ventilation, according to a study.

Slow-tempo music intervention does nothing to improve delirium outcomes in ventilated patients

23 Oct 2025

Ammoxetine for major depressive disorder clears phase II study

22 Oct 2025

In the treatment of patients with major depressive disorder (MDD), ammoxetine is well tolerated and shows superior efficacy relative to placebo, as shown in a phase II study conducted in China.

Ammoxetine for major depressive disorder clears phase II study

22 Oct 2025

Paliperidone 6-month LAI sustains symptomatic, functional remission in schizophrenia at 3 years

18 Oct 2025 by

Patients with schizophrenia who either continued on the LAI paliperidone palmitate (PP) 6-monthly for up to 3 years or transitioned from PP 3-monthly treatment have sustained symptomatic and functional remission, as shown in a post hoc analysis of the single-arm, OLE study PSY3016

Paliperidone 6-month LAI sustains symptomatic, functional remission in schizophrenia at 3 years

18 Oct 2025

GLP-1RA offers protection against mortality, cardiac events for psoriasis patients

15 Oct 2025 by

Patients with psoriasis who are using glucagon-like peptide-1 receptor agonists (GLP-1RAs) appear to have lower risks of mortality and adverse cardiovascular events, according to a retrospective study.

GLP-1RA offers protection against mortality, cardiac events for psoriasis patients

15 Oct 2025

Injuries from explosives, firearms in Gaza surpass those in previous conflicts

11 Oct 2025 by

International healthcare workers deployed to Gaza, Palestine, report experiencing extensive polytrauma (≥2 anatomical regions), complex blast injuries from high yield explosives, firearm-related injuries to upper and lower limbs, and severe disruption to primary care and the treatment of chronic diseases during the ongoing conflict, results of a recent survey have shown.

Injuries from explosives, firearms in Gaza surpass those in previous conflicts

11 Oct 2025

Memantine shows therapeutic potential in children with ASD

09 Oct 2025 by

Treatment with memantine may improve social functioning in children with autism spectrum disorder (ASD), as shown in a small study.

Memantine shows therapeutic potential in children with ASD

09 Oct 2025

Transcutaneous auricular VNS eases constipation, pain in IBS-C

07 Oct 2025 by

The use of transcutaneous auricular vagus nerve stimulation (taVNS) is effective in improving constipation and abdominal pain, as well as anxiety and depression, in patients with constipation-predominant irritable bowel syndrome (IBS-C), reports a study.

Transcutaneous auricular VNS eases constipation, pain in IBS-C

07 Oct 2025

Prenatal antidepressant exposure may elevate risk of postpartum haemorrhage

06 Oct 2025

Women with prenatal exposure to selective serotonin and serotonin-norepinephrine reuptake inhibitors appear to be at increased risk of postpartum haemorrhage, according to a study.

Prenatal antidepressant exposure may elevate risk of postpartum haemorrhage

06 Oct 2025

News & Updates

Filter by Specialty:

Specialty:

Esketamine demonstrates safety in real world

Esketamine demonstrates safety in real world

PHQ, HADS deemed acceptable for poststroke depression screening in Singapore

PHQ, HADS deemed acceptable for poststroke depression screening in Singapore

Slow-tempo music intervention does nothing to improve delirium outcomes in ventilated patients

Slow-tempo music intervention does nothing to improve delirium outcomes in ventilated patients

Ammoxetine for major depressive disorder clears phase II study

Ammoxetine for major depressive disorder clears phase II study

Paliperidone 6-month LAI sustains symptomatic, functional remission in schizophrenia at 3 years

Paliperidone 6-month LAI sustains symptomatic, functional remission in schizophrenia at 3 years

GLP-1RA offers protection against mortality, cardiac events for psoriasis patients

GLP-1RA offers protection against mortality, cardiac events for psoriasis patients

Injuries from explosives, firearms in Gaza surpass those in previous conflicts

Injuries from explosives, firearms in Gaza surpass those in previous conflicts

Memantine shows therapeutic potential in children with ASD

Memantine shows therapeutic potential in children with ASD

Transcutaneous auricular VNS eases constipation, pain in IBS-C

Transcutaneous auricular VNS eases constipation, pain in IBS-C

Prenatal antidepressant exposure may elevate risk of postpartum haemorrhage

Prenatal antidepressant exposure may elevate risk of postpartum haemorrhage